DNA Damage/DNA Repair

The DNA in a human cell receives tens of thousands of damages per day due to both external (exogenous) and internal (endogenous) stress. The exogenous damages are caused by chemical contamination, UV light, ionizing radiation and alkylation/methylation etc, while the endogenous damages are coming from oxidation, alkylation and hydrolysis of bases etc. Since single strand and double strand breaks of DNA will occur after the damage, unrepaired DNA damage leads to cell senescent, apoptosis and malignancies etc. To overcome this threat, cell has developed DNA damage response, to detect DNA damage and mediate its repair.
DNA repair involves multiple mechanisms such as mismatch, base excision, and nucleotide excision repair etc. A group of proteins and pathways are participated in those processes. ATM/ATR kinases and DNA-PK are crucial for the detection of the DNA damage. Chromatin remodelers regulate chromatin accessibility for the DNA repair factors to function. RPA, Rad51 and the fanconi anemia proteins act directly on repairing the DNA damage. p53 network, the RAS GTPase superfamily, and the ubiquitin system also play important part in the DNA damage response. Aberrant DNA damage response is linked to aging, cancer and immune diseases.
-   A8625 CP-466722Target: ATMSummary: ATM inhibitor,potent and reversible A8625 CP-466722Target: ATMSummary: ATM inhibitor,potent and reversible
-   B6114 CC-115Summary: mTOR/DNA-PK inhibitor B6114 CC-115Summary: mTOR/DNA-PK inhibitor
-   B1474 FT-207 (NSC 148958)Summary: DNA/RNA synthesis inhibitor B1474 FT-207 (NSC 148958)Summary: DNA/RNA synthesis inhibitor
-   B3489 CarmustineSummary: cell-cycle phase nonspecific alkylating antineoplastic agent B3489 CarmustineSummary: cell-cycle phase nonspecific alkylating antineoplastic agent
-   A4083 Rocilinostat (ACY-1215)1 CitationTarget: Histone Deacetylases (HDACs)Summary: Selective HDAC6 inhibitor A4083 Rocilinostat (ACY-1215)1 CitationTarget: Histone Deacetylases (HDACs)Summary: Selective HDAC6 inhibitor
-   A4153 BMN 673Summary: Potent PARP inhibitor A4153 BMN 673Summary: Potent PARP inhibitor
-   A3958 Veliparib dihydrochlorideTarget: PARPSummary: PARP-1/PARP-2 inhibitor A3958 Veliparib dihydrochlorideTarget: PARPSummary: PARP-1/PARP-2 inhibitor
-   A2198 GenisteinTarget: Estrogen and Related Receptors|PPAR|PTKSummary: ER agonist A2198 GenisteinTarget: Estrogen and Related Receptors|PPAR|PTKSummary: ER agonist
-   A2097 IfosfamideTarget: DNA AlkylatingSummary: Cytostatic agent A2097 IfosfamideTarget: DNA AlkylatingSummary: Cytostatic agent
-   A8624 CGK733Target: ATM/ATRSummary: ATM/ATR inhibitor,potent and selective A8624 CGK733Target: ATM/ATRSummary: ATM/ATR inhibitor,potent and selective
